PAPER Gu L, Guo Z
SEARCH RESULTS
4891 RESULTS
PAPER Burtscher J, Mallet RT, Burtscher M, Millet GP
Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Ageing Res Rev. 2021 Jul;68:101343. Epub 2021 Apr 15 PubMed: 33862277PAPER Chen Z, Yu Q, Yu Q, Johnson J, Shipman R, Zhong X, Huang J, Asthana S, Carlsson C, Okonkwo O, Li L
In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
Mol Cell Proteomics. 2021 Apr 20;20:100081. PubMed: 33862227PAPER Babaee S, Chehardoli G, Akbarzadeh T, Zolfigol MA, Mahdavi M, Rastegari A, Homayouni Moghadam F, Najafi Z
Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
Chem Biodivers. 2021 Jun;18(6):e2000924. Epub 2021 May 3 PubMed: 33861892PAPER Wilkenfeld DA, Orbell SL, Lingler JH
Ethical Considerations in Communicating Alzheimer's Disease Neuroimaging Biomarker Test Results to Symptomatic Individuals.
Neurotherapeutics. 2021 Apr;18(2):673-685. Epub 2021 Apr 15 PubMed: 33860462PAPER Cisbani G, Rivest S
Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls.
Mol Psychiatry. 2021 Apr 14; PubMed: 33854189PAPER Berlot R, Koritnik B, Pirtošek Z, Ray NJ
Preserved cholinergic forebrain integrity reduces structural connectome vulnerability in mild cognitive impairment.
J Neurol Sci. 2021 Jun 15;425:117443. Epub 2021 Apr 9 PubMed: 33865078PAPER Gómez-Soria I, Andrés Esteban EM, Gómez Bruton A, Peralta-Marrupe P
[Long-term effect analysis of a cognitive stimulation program in mild cognitive impairment elderly in Primary Care: A randomized controlled trial].
Aten Primaria. 2021 Aug-Sep;53(7):102053. Epub 2021 Apr 14 PubMed: 33865010PAPER Araújo AR, Castro VI, Reis RL, Pires RA
Glucosamine and Its Analogues as Modulators of Amyloid-β Toxicity.
ACS Med Chem Lett. 2021 Apr 8;12(4):548-554. Epub 2021 Mar 24 PubMed: 33859794PAPER Wan HL, Hong XY, Zhao ZH, Li T, Zhang BG, Liu Q, Wang Q, Zhao S, Wang JZ, Shen XF, Liu GP
STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer's disease animal model.
Theranostics. 2021;11(11):5511-5524. Epub 2021 Mar 13 PubMed: 33859760PAPER Cammisuli DM, Pagni C, Palermo G, Frosini D, Bonaccorsi J, Radicchi C, Cintoli S, Tommasini L, Tognoni G, Ceravolo R, Bonuccelli U
Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay.
Front Psychol. 2021;12:546476. Epub 2021 Mar 30 PubMed: 33859587PAPER Liu ZQ, Liu K, Liu ZF, Cong L, Lei MY, Ma Z, Li J, Deng Y, Liu W, Xu B
Manganese-induced alpha-synuclein overexpression aggravates mitochondrial damage by repressing PINK1/Parkin-mediated mitophagy.
Food Chem Toxicol. 2021 Jun;152:112213. Epub 2021 Apr 20 PubMed: 33862121Terrence Gerlich
Joel Petch
Kent and Medway Medical SchoolCanterbury , United Kingdom
PAPER Ovsepian SV, O'Leary VB, Hoschl C, Zaborszky L
Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis.
Neurosci Lett. 2021 Jun 11;755:135895. Epub 2021 Apr 20 PubMed: 33862141Current Filters
- Date Range : Jan 2021 to Apr 2021 x